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True cadence and step accumulation outcomes are not the same. 
Stepping was spread across the same number of mins/d for those with IC as controls. 
People with intermittent claudication (IC) take fewer high cadences steps than matched 
controls. 
To avoid ambiguity, ‘cadence’ must be reserved for ‘true cadence’: stepping rate during 
stepping. 
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ABSTRACT 
‘True cadence’ is the rate of stepping during the period of stepping.  ‘Step accumulation’ is 
the steps within an epoch of time (e.g. 1min).  These terms have been used interchangeably 
in the literature.  These outcomes are compared within a population with intermittent 
claudication (IC).  Multiday, 24hr stepping activity of those with IC (30) and controls (30) was 
measured objectively using the activPAL physical activity monitor.  ‘True cadence’ and ‘step 
accumulation’ outcomes were calculated.  Those with IC took fewer steps/d 6,531±2,712 
than controls 8692±2945 (P=0.003).  However, these steps were taken within approximately 
the same number of minute epochs (IC 301±100mins/d; controls 300±70mins/d, P=0.894) 
with only slightly lower true cadence (IC 69(IQ 66,72)steps/min; controls 72(IQ 
68,76)steps/min, P=0.026), giving substantially lower step accumulation (IC 22(IQ 
19,24)steps/min; controls 30(IQ 23,34)steps/min) (P<0.001).  However, the true cadence of 
stepping within the blocks of the 1, 5, 20, 30 and 60 minutes with the maximum number of 
steps accumulated was lower for those with IC than controls (P<0.05). Those with IC took 
1300 steps fewer per day above a true cadence of 90steps/min. True cadence and step 
accumulation outcomes were radically different for the outcomes examined.  ‘True cadence’ 
and ‘step accumulation’ were not equivalent in those with IC or controls.  The measurement 
of true cadence in the population of people with IC provides information about their 
stepping rate during the time they are stepping.  True cadence should be used to correctly 
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Stepping rate; cadence; objective monitoring; walking; activity; intermittent claudication; 
peripheral arterial disease   
 
 
Page 4 of 22 
 
INTRODUCTION 
The rate of stepping is conventionally termed ‘cadence’.  This is typically measured in terms 
of steps per time interval.  This description of stepping rate has been used ambiguously in 
the literature1.  It is important that clear definitions of outcomes are reported so that they 
can be correctly interpreted.  
One example where unambiguous characterisation of stepping rate is required is in the 
assessment of the clinical condition of intermittent claudication (IC).  IC is a symptom of leg 
pain caused by peripheral arterial disease (PAD) associated with narrowing of arteries2,3.  
Arterial blockage prevents sufficient blood supply to the leg muscles, making continuous 
walking challenging4.  Individuals affected by IC have reported the need to take regular 
breaks due to ischaemic pain resulting in fragmented walking5-7.  Also those with PAD have 
an exaggerated cardiovascular response to a constant-load walking exercise8.  To reduce the 
possibility of claudication pain they reduce their preferred walking speed and step length7.  
This could reduce the cardiovascular load, allowing extended walking periods before onset 
of ischaemic pain.  Therefore, the quantification of cadence could be used to describe 
patient’s current condition and to characterise progression or recovery following 
rehabilitation. 
Evidence suggests that people with IC take, on average, a smaller number of steps per 
minute time block (sometimes referred to as an epoch) compared to an unimpaired age 
matched population9, i.e. that people with IC spread out their stepping activity.  Gardner et 
al9 also reported that participants with IC took fewer steps at specified medium and high 
number of steps per minute epoch than controls. Gardner et al reported their results as 
‘cadence’, however, their outcomes would more accurately be termed ‘step accumulation’.  
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Step accumulation is the number of steps taken within a defined time period (e.g. an epoch 
of one minute), whereas cadence is the rate of stepping during the actual time spent 
stepping.  Dall et al1, demonstrated that adults rarely walk continuously for a minute or 
longer, meaning that steps accumulated per minute time block, as described by Gardner et 
al9, could not be equivalent to true cadence.  The lack of clarity in terminology used, could 
lead to misunderstanding of research findings.  The terms ‘step accumulation’ and ‘true 
cadence’ are used here for clarity. 
To investigate the importance of using unambiguous terminology to describe stepping rate, 
this paper examines the true cadence of walking in those with IC compared to unaffected 
peers.  In light of recent evidence of the difference between the concepts of step 
accumulation and true cadence1 both of these measurements are presented to allow 
comparison with literature and to advance understanding of walking behaviour in those 
with IC.  The presentation of both quantities for both those with IC and for those without is 
used to investigate any differences between outcomes between these groups.  It was 
hypothesised that those with IC would not only take fewer steps overall, but would also 
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METHODS 
Thirty participants with IC were recruited consecutively from an outpatient vascular 
service5.  Ankle Brachial Pressure index (ABPi) and duration of IC were recorded.  To confirm 
IC diagnosis for those with high ABPi an exercise test (using a calf ergonometer) was 
performed in conjunction with Duplex ultrasound and/or Magnetic Resonance Angiogram.  
Ethical approval was obtained from NHS Tayside B Research Ethics Committee. 
Thirty controls matched for age (±5years) and gender were selected from a database of 
physical activity records for ‘healthy’ individuals at Glasgow Caledonian University.  Controls 
had been recruited through contacts of staff at Glasgow Caledonian University, lived in the 
community and had no medical condition affecting mobility.  Ethical approval was gained 
from Glasgow Caledonian University School of Health and Life Sciences Ethics Committee.   
All participants gave informed consent to take part in the study.  Gender, age, height and 
weight were recorded.   
The free-living activity of both groups was monitored using an activPALTM (PAL Technologies 
Ltd. Glasgow, UK) activity monitor for 7 consecutive days. The monitor is a small, light-
weight, thigh-worn self-contained device.  This monitor has been validated for classifying 
upright, sedentary and standing events as well as stepping in a range of populations10-14. 
The monitor was attached to the anterior part of the right thigh using either a waterproof 
dressing (IC participants: Opsite FlexifixTM) or a hydrogel pad (controls: PALStickiesTM, PAL 
Technologies Ltd. Glasgow, UK).  Control participants had the option of removing the 
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The data from the activPAL was first analysed using proprietary software to obtain a time-
stamped event history of posture (sit/stand), strides taken and associated stepping time.  
The activPAL outputs the start time and duration (to the nearest 0.1s) of each stride.  This 
output was used to determine stepping time.  The outcome data was examined visually 
(stepping and posture) to identify any non-compliance (e.g. very few steps in a day, very few 
sit to stand postural transitions or extended periods of apparent sitting time which were 
highly uncharacteristic of the participants overall profile).  Only complete 24h days were 
used in the analysis.   
The whole period was then broken down into one-minute epochs and the time spent 
stepping during each minute and the associated steps (strides x 2) determined using custom 
software (Matlab, Mathworks Ltd.). 
 
Outcomes 
All outcomes were analysed both in terms of true cadence1 (total number of steps divided 
by the stepping time) and step accumulation (total number of steps taken per minute) (the 
method used by Gardner et al9).  
Figure 1 provides an illustration of the difference between true cadence and step 
accumulation within one minute epochs.  Within the first minute 25+20+15=60steps were 
taken, giving a step accumulation of 60 steps.  However, the time taken to complete these 
steps was 15+8+7=30s.  Therefore, the true cadence was 60/0.5=120steps/min.  In the 
second minute epoch the entire period was spent stepping and 60 steps were taken. 
Therefore, the true cadence was 60steps/min with a step accumulation of 60steps/min.  
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This illustrates the differences between the two outcomes for minutes with discontinuous 
stepping. 
The overall stepping activity was described by the total number of steps/day, the number of 
minutes which had stepping in and the mean step accumulation in these minutes.  The 
mean true cadence of all minute epochs with steps in was also calculated.  To allow 
comparison with the analysis of Gardner et al9 the minutes with <30, >=30&<60, and >=60 
steps were identified.  Both the true cadence and the step accumulation of these minutes 
were calculated.  A large proportion of minutes with stepping in had true cadence 
>=60steps/min.  Therefore, to further analyse the true cadence outcomes the upper range 
was subdivided: >=60&<90, >=90&<120, >=120steps/min. 
Following the methods of Gardner et al9 minutes were selected that represented the ‘burst 
activity’, characterised as the one-minute and five-minute blocks which had the maximum 
number of steps accumulated.  ‘Endurance’ was characterised by finding the blocks of 20, 30 
and 60 minutes which contained the maximum total number of steps.  The ‘Peak Activity 
Index’ was calculated within the 30 single minute epochs with the highest step 
accumulation.  True cadence and step accumulation were calculated for these outcomes.  
 
Statistical analysis 
Outcome distributions were examined for normality (Shapiro-Wilk).  Mann Whitney U or 
unpaired t-tests were applied as appropriate to examine differences between outcomes for 
IC and control groups.  A significance level of P<0.05 was used. Data are reported as either 
mean±standard deviation or median (25th quartile, 75th quartile).  For multiple tests (e.g. 
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across several ranges of cadence) a Bonferroni correction was applied.  All analysis was 








Between those with IC and controls there were no significant differences in age, gender, 
height, weight or BMI (all P>0.05) (Table 1). All participants wore the monitor for 7 full days 
except 2 controls who wore the monitor for 5 days only.  More of the controls (37%) were in 
employment that those with IC (20%).  The mean duration of IC was 4.1±4.9y with 
participants having a mean Ankle Brachial Pressure Index (ABPi) of 0.83±0.28. 
 
The mean number of steps per day for those with IC was significantly lower at 6531±2712 
than controls 8692±2945 (P=0.003).  However, this stepping activity was taken in 
approximately the same number of one-minute epochs (IC 301±100 and controls 300±70) 
(P=0.894).  Thus those with IC and the controls had approximately the same number of one 
minute periods with stepping activity. 
 
True cadence and step accumulation outcomes within stepping rate bands were radically 
different, demonstrating opposite trends, for both those with IC and controls (Figure 2A).  
True cadence demonstrated an increasing number of minutes and step accumulation a 
decreasing number of minutes at higher stepping rates: 
For both groups the majority of one-minute epochs with stepping had a true cadence 
greater than 60 steps/min (IC 190(147,240)mins/d, controls 203(165,232)mins/d) (P=0.679) 
(Figure 2A).  There was, however, also a large number of minutes with true cadence 
>=30&<60 steps/min for both those with IC (95(59,127)mins/d) and the controls 
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(87(64,105)mins/d) (P=0.751).  There were very few one-minute epochs with stepping 
where the true cadence was <30 steps/min (IC 14(8,19)mins/d, controls 12(10,15)mins/d) 
(P=0.287).  The step accumulation for these same minutes demonstrated the opposite trend 
(Figure 2A) with the majority of one-minute epochs having low step accumulation <30 
steps/min (IC 242(158,289)mins/d, controls 184(167,238)mins/d) (P=0.147).  However, the 
only statistically significant difference in outcomes between the groups was for the number 
of minutes of step accumulation greater than 60 steps/min, where those with IC had lower 
mins/d (20(13,31)mins/d) than the controls (45(22,60)mins/d) (P<0.001).   
Outcomes of the number of steps classified as being within each stepping rate range (Figure 
2B) were again quite different when characterised by true cadence and step accumulation.  
Low (<30steps/min) true cadence stepping was very limited in comparison to that 
determined by step accumulation, whereas high (>=60 steps/min) stepping rate steps 
determined by true cadence were much higher than determined by step accumulation: 
For the minute-epochs taken at a high true cadence (>60steps/min) the IC group took 
significantly fewer steps (5,258(3,843, 6,761)steps/d) than the control group (7624(5353, 
9050)steps/d) (P=0.003).  There were no differences between the numbers of steps taken in 
the low or medium ranges of true cadence (Figure 2B).  For step accumulation those with IC 
took significantly fewer steps in the high (>60 steps/min) step accumulation range 
(1700(1100, 3082)steps/d) than controls (4255(1948, 5949)steps/d) (P<0.001).   
The differences between true cadence and step accumulation for steps per day were not 
the same between the groups: Similar true cadence distributions (Figure 2B) were 
contrasted by opposite trends in step accumulation distributions. 
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Gardner et al’s9 ‘burst’ and ‘endurance’ measures of stepping within the minutes with the 
most activity demonstrated similar trends between the true cadence and step accumulation 
outcomes (Figures 3A and 3B respectively).  However, only the ‘Maximum 1-min’ outcomes 
were of similar magnitude with all other true cadence outcomes higher than the step 
accumulation outcomes: 
All measures of ‘burst’, ‘endurance’ and ‘peak activity index’ were significantly different 
between the IC and control groups with the IC group having lower true cadence than the 
control group (Figure 3A).  Similarly the outcomes based on step accumulation were also all 
significantly different with the IC group having a lower number of steps per minute-epoch 
than the controls (Figure 3B).  Whilst for all the ‘burst’, ‘endurance’ and ‘peak activity index’ 
outcomes the median true cadence measures were all above 80 steps/minute, the steps 
accumulated per minute were as low as 27 for the maximum 60 min endurance category.  
Of all the minutes containing stepping the median true cadence of walking was different 
between the IC group (69(66,72)steps/min) and the control group (72(68,76)steps/min) 
(P=0.026).  This difference was, however, small compared to the average values exhibited.  
This small difference was associated with a large difference in the number of steps 
accumulated per minute (IC 22(19,24)steps/min compared to controls 30(23,34)steps/min) 
(P<0.001).  The differences between outcomes when presented by true cadence as 
compared to step accumulation appeared to be the same for both those with IC and the 
controls:  All the true cadence and step accumulation ‘burst’ and ‘endurance’ outcomes 
were lower for the IC group.   
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When the upper range of true cadence (>60steps/min) was subdivided further it was 
observed that there was a trend (not significant) for the IC group to have fewer minutes 
with a true cadence above 90 steps per minute compared to the control group (Figure 4A).  
This was associated, however, with a significant difference in the number of steps taken in 
the upper true cadence ranges (Table 2):  The IC group took far fewer steps on average at 
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DISCUSSION 
Stepping rate has been described ambiguously in the literature1.  The terms ‘true cadence’ 
and ‘step accumulation’ have been used here in order to illustrate differences in outcomes 
that result when using different definitions of stepping rate.  The clinical population of those 
with intermittent claudication was selected as it was hypothesised that this population 
would have altered patterns of stepping activity due to pain when walking.  It has already 
been reported by Gardner et al9 that this population appear to use different distributions of 
stepping than an age matched group without IC.  However, Gardner et al’s use of ‘step 
accumulation’ means that it is not possible to know the actual stepping rate used during 
periods of stepping.  This information can only come from true cadence:  The rate of 
stepping when actually taking steps. 
The results of the current study confirm that those with IC take fewer steps on average per 
day than those without (IC 6531±2712, controls 8692±2945 steps/day).  This difference of 
over 2000 steps per day between the IC and control groups is very similar to that reported 
by Gardner et al9 (6300 to 8400steps/d). The number of minutes within the day that 
contained walking was also similar for controls between this study (300±70mins/d) and 
Gardner et al9 (312±96mins/d).  Those with IC in the current study, however, distributed 
their walking across a larger number of minutes than previously reported (301±100mins/d 
current study, compared to 264±109mins/d9).  This was associated with a similar average 
step accumulation in this study (IC 22(19,24)) compared to that reported by Gardner et al9 
(IC 23.6±5.8).  The higher number of steps taken per day in the current study may have been 
due to lower average body weight and a higher proportion of male participants in the 
current study (60%) compared to Gardner et al’s population (IC 46%, controls 55%).  Also 
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the ABPi of the IC participants in the current study (0.83 ± 0.28) was higher than that 
reported by Gardner et al (0.71±0.21) indicating that they were more mildly affected.  The 
population recruited here were at the lower end of the symptom scale being relatively 
mildly affected15.  It might be expected that those with a more advanced disease state might 
demonstrate greater impairment in walking performance.  Whilst the control population 
self-reported as asymptomatic their ABPi was not assessed nor were further medical 
examinations performed.  It is possible that unrecorded co-morbid conditions and 
cardiovascular risk factors may have influenced the results. 
 
Figure 2A demonstrates conclusively that true cadence and step accumulation for this 
clinical population are not equivalent, with results based on the two measures giving 
completely different trends for stepping rate.  This emphasises the importance of using clear 
terminology to describe stepping rate.  These differences confirm that the populations 
studied tended to accumulate most of their walking in periods of less than one minute1.   
The number of steps taken within the minutes identified by true cadence and step 
accumulation is again radically different (Figure 2B), but with similar trends for a lower 
number of high stepping rate steps for those with IC compared to controls in the 
>60steps/min range.  There was a difference in pattern of distribution of steps taken with 
stepping rate between the IC group and the controls for step accumulation in comparison to 
true cadence (Figure 2B).  Step accumulation gives the impression that the IC group have 
predominantly low stepping rate steps and the controls have predominantly high stepping 
rate steps.  This difference is not present when examined by true cadence.  This highlights 
that there is not the same relationship between step accumulation and true cadence for 
 
 
Page 16 of 22 
 
these populations.  This difference arises due to the particular distribution of amount of 
time spent stepping per minute within the two groups. 
The ‘burst’, ‘endurance’ and ‘peak activity index’ outcomes (Figure 3) advocated by Gardner 
et al1 provide quantitative insight into the minutes with the largest number of steps.  Our 
hypothesis that those with IC would demonstrate lower true cadence outcomes is proven 
(Figure 3A) for these outcomes.  Also this analysis demonstrates considerable differences 
between true cadence and step accumulation outcomes.  Although these peak indicators of 
stepping were different between those with IC and controls the average true cadence in all 
minutes with stepping was different only by a small amount (3 steps/min) between groups.  
This confirms that those with IC use a pattern of stepping with lower sustained high true 
cadence, spreading out their stepping activity more than controls, but within the same 
number of minute epochs. 
When true cadence is used to describe stepping rate (Figure 4) evidence emerges that it is 
only in the higher ranges of cadence, above 90steps/min, that there are differences 
between the groups.  With a median of only 2000steps/d, those with IC took approximately 
1300steps/d fewer above this threshold than controls (Table 2). 
Analysing stepping using step accumulation, and reporting this as cadence, gives an 
impression that people with Intermittent Claudication walk at a low stepping rate.  The 
results from this study show that people with Intermittent Claudication walk at much higher 
true cadences than have previously been reported, with mean true cadences per minute 
epoch being only slightly lower than that of a matched control group. 
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Assessment of stepping activity against physical activity guidelines might be important for 
describing current activity engagement within this clinical population.  The performance of 
moderate to vigorous physical activity (MVPA) is considered to take place above thresholds 
of stepping rate determined for continuous walking (e.g. a true cadence of 
100steps/min)16,17.  The current analysis demonstrates the large differences in outcomes 
that might arise if stepping rate is inadvertently described using step accumulation and not 
true cadence.   
Whilst this true cadence based analysis of minute epoch data provides some insight into the 
stepping rate distribution, it does not provide information on the overall stepping events 
that are occurring.  If a stepping event (continuous stepping without a break) crossed the 
boundary of the one-minute epochs then it would have been split between two or more 
epochs.  The only way to overcome this shortcoming of the current analysis would be to 
examine the data in an event-based manner treating the time series as continuous and 
composed of discrete events of stepping and non-stepping time18. Once a stepping event 
had been identified the cadence of this whole event and the distribution of cadence within 
this event could be used to describe stepping intensity. 
 
CONCLUSIONS 
True cadence should be used to correctly describe the rate of stepping as it is performed.  
True cadence outcomes are not the same as step accumulations outcomes.  Those with IC 
had approximately the same number of minutes per day with stepping in, but they 
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accumulated fewer steps within these minutes than controls.  Those with IC performed 
1300 fewer steps per day at high true cadence (>90 steps/min) than controls. 
The measurement of true cadence under free-living conditions in the population of people 
with IC provides insight into the effect of their condition on stepping performance.. 
Stepping rate should be described unambiguously.  Analysis of stepping using true cadence 
and step accumulation are not equivalent.   
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Calculation of true cadence based on the number of steps taken and the time spent stepping.  
Two one minute epochs are illustrated. Time periods where no steps are taken are indicated 
by dark shading.  Time periods where stepping occurred are indicated by light shading, with 
the number of steps taken and the time to take these steps indicated. 
 
Figure 2 
Minutes per day (A) and steps per day (B) (median and interquartile range) within ranges of 
true cadence within minute epochs (left two sets of three columns in each figure) and steps 
accumulated within minute epochs (right two sets of three columns in each figure) for IC and 
control groups. **=P<.01, *=P<.05.  
 
Figure 3  
Outcomes (median and interquartile range) based on true cadence of steps taken within each 
minute epoch (A) and the steps accumulated per minute epoch (B) for the IC and control 
groups. See methods section for details of calculation of each outcome. **=P<.01, *=P<.05. 
 
Figure 4 
The number of minutes with stepping in within ranges of true cadence (A) and the number of 
steps taken within ranges of true cadence (B).  Median and interquartile range for both IC and 





Calculation of true cadence based on the number of steps taken and the time spent stepping.  
Two one minute epochs are illustrated. Time periods where no steps are taken are indicated 
by dark shading.  Time periods where stepping occurred are indicated by light shading, with 
the number of steps taken and the time to take these steps indicated. 
 
Figure 2 
Minutes per day (A) and steps per day (B) (median and interquartile range) within ranges of 
true cadence within minute epochs (left two sets of three columns in each figure) and steps 
accumulated within minute epochs (right two sets of three columns in each figure) for IC and 
control groups. **=P<.01, *=P<.05.  
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25 20 15 60 steps 
      15s            8s                7s                                     60s Time stepping (s) 
Number of 
continuous steps 
0                                                                  1                                                               2 
                                                            Time (minutes) 
Steps accumulation:          
              25+20+15 =           60                                                            60 
True cadence: 
 60 steps/0.5mins =         120 steps/min         60 steps/1min =   60 steps/min 
























































































































Table 1     Participant details 
Characteristic Participants with IC (30) Controls (30) 
Age (years) 67.2 ± 9.7 66.8 ± 10.5 
Gender (% Male) 60% 60% 
Height (m) 1.67 ± 0.12 1.71 ± 0.10 
Weight (kg) 73.4 ± 17.8 75.2 ± 13.9 
BMI (kg/m
2
) 26.2 ± 4.0 26.0 ± 4.4 
Occupation*   
Full-time 17% 30% 
Part-time 3% 7% 
Retired 80% 63% 
Number of days of monitor wear All wore for 7 days 28 wore 7 days 
2 = 5 days 
 
*Pearson’s Chi square P=0.027.  IC = Intermittent Claudication. Data are presented as mean 





Table 2  Number of minutes per day with stepping within true cadence range and number of 










percentile).   
 
 
 Stepping within True Cadence range 
 Participants with 
IC 
Controls Participants with 
IC 
Controls 
True cadence range Minutes per day with stepping in true 
cadence range 
Steps per day within true cadence range 
<30 steps/min 14 (8, 19) 12 (10, 15) 40 (21, 62) 34 (24, 42) 
>=30 and <60 
steps/min 
95 (59, 127) 87 (64, 105) 1050 (697, 1494) 1047 (786, 1496) 
>=60 and <90 
steps/min 
125 (107, 157) 126 (100, 146) 2657 (2309, 3632) 3235 (2538, 3865) 
>=90 and <120 
steps/min 
53 (40, 65) 65 (47, 80) 2007 (1183, 2934) 3043 (1957, 5199)
 
* 
>=120 steps/min 1 (1, 2) 4 (1, 10)* 8 (4, 70) 253 (17, 1053)
 
* 
3 
 
 
